| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 32,193 | 35,286 | 39,914 | 42,779 | | Cost of Revenue | 20,562 | 21,379 | 21,061 | 21,532 | | | Gross Profit | 11,631 | 13,907 | 18,853 | 21,247 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,708 | 17,301 | 20,847 | 17,321 | | Non Recurring |
-
| 18,373 |
-
| 109,701 | | Others | 12,311 | 29,332 | 26,562 | 30,615 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (17,388) | (51,099) | (28,556) | (136,390) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (17,388) | (51,099) | (28,556) | (136,390) | | Interest Expense | 2,875 | 3,165 | 3,065 | 2,381 | | Income Before Tax | (20,263) | (54,264) | (31,621) | (138,771) | | Income Tax Expense | (1,811) | 34,310 | (11,472) | (17,326) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,452) | (88,574) | (20,149) | (121,445) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,452) | (88,574) | (20,149) | (121,445) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,452) | ($88,574) | ($20,149) | ($121,445) |
|
0.26% Nasdaq 0.00%
Income Statement
